Dawei Rong
- Cancer Research top 1%
- MicroRNA in disease regulation 8
- Cancer-related molecular mechanisms research 8
- Hepatology top 5%
- Molecular Biology top 5%
- Circular RNAs in diseases 10
- RNA modifications and cancer 3
- Immunology top 5%
- Immune cells in cancer 8
- Immune Cell Function and Interaction 3
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 10
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 6
- Journals
- Cancer Biomarkers (2 papers)Frontiers in Cell and Developmental Biology (2 papers)International Journal of Biological Sciences (2 papers)
- Partner nations
- ChinaGermanyUnited States
In The Last Decade
Dawei Rong
35 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 97
- Cancer Research 1.4k
- Hepatology 266
- Molecular Biology 1.8k
- Immunology 509
- Oncology 598
Countries citing papers authored by Dawei Rong
This map shows the geographic impact of Dawei Rong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawei Rong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawei Rong more than expected).
Fields of papers citing papers by Dawei Rong
This network shows the impact of papers produced by Dawei Rong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawei Rong. The network helps show where Dawei Rong may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Dawei Rong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 17 | |
| 2 | 2023 | 35 | |
| 3 | 2023 | 4 | |
| 4 | 2022 | 57 | |
| 5 | 2022 | 29 | |
| 6 | 2022 | 12 | |
| 7 | 2022 | 70 | |
| 8 | 2022 | 7 | |
| 9 | 2022 | 5 | |
| 10 | 2021 | 23 | |
| 11 | 2021 | 5 | |
| 12 | 2021 | 77 | |
| 13 | 2021 | 65 | |
| 14 | 2021 | 62 | |
| 15 | 2021 | 110 | |
| 16 | 2021 | 53 | |
| 17 | 2021 | 22 | |
| 18 | The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspectsbreakdown → | 2020 | 752 |
| 19 | 2019 | 42 | |
| 20 | 2018 | 28 |
About Dawei Rong
Dawei Rong is a scholar working on Cancer Research, Oncology, Immunology, Molecular Biology and Hepatology, having authored 35 papers that have together received 2.8k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (10 papers), Circular RNAs in diseases (10 papers), MicroRNA in disease regulation (8 papers), Immune cells in cancer (8 papers), Cancer-related molecular mechanisms research (8 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers), Immune Cell Function and Interaction (3 papers) and RNA modifications and cancer (3 papers). The work is most often cited by research in Cancer Research (1.4k citations), Hepatology (266 citations), Molecular Biology (1.8k citations), Immunology (509 citations) and Oncology (598 citations). Dawei Rong has collaborated with scholars based in China, Germany and United States. Frequent co-authors include Weiwei Tang, Xuehao Wang, Betty Zhang, Hongyong Cao, Fan Wu, Kai Fu, Wenling Zhang, Ye Cheng, Zhouxiao Li and Handong Sun. Their work appears in journals such as Cancer Biomarkers, Frontiers in Cell and Developmental Biology, International Journal of Biological Sciences, OncoTargets and Therapy and Annals of Translational Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.